Intellia Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of June 2020: 1.66x

Intellia Therapeutics Inc cash flow reinvestment rate. Intellia Therapeutics Inc (NTLA) has a Cash Flow Reinvestment Rate of 1.66x as of June 2020, reinvesting $95.03 Million (capex $1.04 Million plus investments $94.00 Million) from operating cash flow of $57.42 Million. Explore debt repayment capacity of Intellia Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

1.66x

(Capex + Investments) / Operating CF

Total Reinvested

$95.03 Million

Capex + Investments

Operating Cash Flow

$57.42 Million

USD

Capital Expenditures

$1.04 Million

USD

Cash Flow Reinvestment Rate of Intellia Therapeutics Inc (2016–2016)

Cash flow reinvestment rate of Intellia Therapeutics Inc from 2016 to 2016. Historical reinvestment intensity for Intellia Therapeutics Inc across 1 annual periods. Explore Intellia Therapeutics Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Intellia Therapeutics Inc Cash Flow Reinvestment Rate by Year (2016–2016)

Intellia Therapeutics Inc cash flow reinvestment rate by year from 2016 to 2016. Year-by-year capital reinvestment analysis for Intellia Therapeutics Inc. For the full cash flow conversion analysis, see Intellia Therapeutics Inc cash conversion from operations.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2016	0.34x	$12.33 Million	$36.11 Million	$6.17 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow